Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
37,778,373
-
Total 13F shares
-
14,612,401
-
Share change
-
+3,182,068
-
Total reported value
-
$309,636,635
-
Price per share
-
$21.19
-
Number of holders
-
44
-
Value change
-
+$67,427,487
-
Number of buys
-
27
-
Number of sells
-
7
Institutional Holders of Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) as of Q1 2023
As of 31 Mar 2023,
Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,612,401 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, Novo Holdings A/S, ORBIMED ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., 5AM Venture Management, LLC, Logos Global Management LP, VANGUARD GROUP INC, Rock Springs Capital Management LP, and Foresite Capital Management V, LLC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.